Previous close | 13,274.00 |
Open | 13,250.00 |
Bid | 13,256.00 x 0 |
Ask | 13,258.00 x 0 |
Day's range | 13,172.00 - 13,330.00 |
52-week range | 9,461.00 - 13,330.00 |
Volume | |
Avg. volume | 1,734,831 |
Market cap | 205.784B |
Beta (5Y monthly) | 0.15 |
PE ratio (TTM) | 42.41 |
EPS (TTM) | 3.13 |
Earnings date | 12 Nov 2024 |
Forward dividend & yield | 2.34 (1.76%) |
Ex-dividend date | 08 Aug 2024 |
1y target est | 133.44 |
QGEN's expanded collaboration with AstraZeneca to focus on developing companion diagnostics beyond oncology.
Merck (MRK) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Visa, AstraZeneca, Disney, FitLife Brands and Utah Medical are included in this Analyst Blog.